Women's Imaging Insider

Dear AuntMinnieEurope Women's Imaging Insider,

Over two years have passed since the European Society of Breast Imaging recommended MRI screening for women with extremely dense breasts, but debate continues over how to implement it in breast cancer screening programs.

Information about women's experiences and their willingness to reattend is vital here, so a new Dutch study is bound to generate considerable attention. Our news report includes analysis by two co-authors, including Dr. Ritse Mann, chair of the EUSOBI scientific committee.

Swedish researchers have also published novel findings about this patient group. Recurrence-free breast cancer survival is less likely in women with high breast density compared with women with low density, according to researchers from Lund University. They found that these results were especially evident for women with screening-detected cancers, but they reported no association between mammographic tumor appearance and recurrence-free survival.

Meanwhile, U.K. authors have highlighted MRI's benefits as a prenatal assessment tool. As well as giving insight into the immediate pathophysiological impact of preeclampsia, the modality can be a valuable tool for risk stratification, both antenatally and when considering longer-term cardiovascular risk in women, they say.

Our editorial advisor Dr. Filippo Pesapane from Milan is doing great work in breast AI. In an uplifting video, he talks about his current projects, and near the end of the interview, he reveals his unbridled joy over becoming a new parent. Don't miss it!

In another recent study, Turkish investigators reported that AI can boost the detection of interval breast cancers. They found that when AI was implemented into breast cancer screening in a middle-income country, it achieved high sensitivity and specificity in detecting interval cancers that were initially labeled as BI-RADS 1 or 2.

Philip Ward
Editor in Chief

Page 1 of 164
Next Page